DRKS00011602已完成不适用
VIVID-ONValdoxan® improves vitality in depression with anhedonia - VIVID-O
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 970
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •patients with episodes of major depression, who are intended for a therapy with the antidepressant Valdoxan® according to the indication.
排除标准
- •- contraindications to SmPC
- •- patients under 18 years
研究者
相似试验
已完成
4 期
VIVALDI Praxis: Valdoxan improves depressive symptoms and normalizes circadian rhythmsEpisodes of major depressionMental and Behavioural DisordersRecurrent depressive disorderISRCTN18801971Servier Deutschland GmbH (Germany)3,600
已完成
4 期
VIVALDI: Valdoxan® improves depressive symptoms and normalises circadian rhythmsEpisodes of major depressionMental and Behavioural DisordersDepressive episodeISRCTN49411996Servier Deutschland GmbH (Germany)8,000
招募中
不适用
VR Moodboost in the treatment of depressioNL-OMON55986Academisch Medisch Centrum10
已完成
不适用
Valdoxan ImproVes depRession with anxiEty symptoms (VIVRE)Episodes of major depressionMental and Behavioural DisordersRecurrent depressive disorder, current episode severeISRCTN20363887Servier Deutschland GmbH (Germany)3,000
尚未招募
Unknown
ightMood Intervention to reduce depression symptoms in obese adults: A randomized-controlled online intervention studyObese adults with depressive symptomsDRKS00029219VR-Universitätsklinik Essen128